LivaNova (LIVN) Enterprise Value (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.06% |
| Jun 30, 2025 | 19.43% |
| Mar 31, 2025 | -72.18% |
| Dec 31, 2024 | -22.60% |
| Sep 30, 2024 | -6.25% |
| Jun 30, 2024 | 6.49% |
| Mar 31, 2024 | -15.44% |
| Dec 31, 2023 | -2.08% |
| Sep 30, 2023 | -33.89% |
| Jun 30, 2023 | 34.30% |
| Mar 31, 2023 | 4.91% |
| Dec 31, 2022 | -29.45% |
| Sep 30, 2022 | 21.64% |
| Jun 30, 2022 | 4.31% |
| Mar 31, 2022 | -16.97% |
| Dec 31, 2021 | -13.27% |
| Sep 30, 2021 | 36.11% |
| Jun 30, 2021 | -72.15% |
| Mar 31, 2021 | 0.92% |
| Dec 31, 2020 | -11.88% |
| Sep 30, 2020 | 2.04% |
| Jun 30, 2020 | -84.82% |
| Mar 31, 2020 | -105.80% |
| Dec 31, 2019 | 18.82% |
| Sep 30, 2019 | -69.20% |
| Jun 30, 2019 | 12.34% |
| Mar 31, 2019 | -7.57% |
| Dec 31, 2018 | 40.96% |
| Sep 30, 2018 | -68.74% |
| Jun 30, 2018 | 27.07% |
| Mar 31, 2018 | 30.61% |
| Dec 31, 2017 | -43.67% |
| Sep 30, 2017 | -52.63% |
| Jun 30, 2017 | 31.93% |
| Mar 31, 2017 | -57.63% |
| Dec 31, 2016 | 37.47% |
| Sep 30, 2016 | 10.23% |
| Jun 30, 2016 | 24.95% |
| Mar 31, 2016 | 21.03% |
| Oct 18, 2015 | -21.20% |
| Jul 24, 2015 | -7.38% |